Ethanol lock and risk of hemodialysis catheter infection in critically III patients a randomized controlled trial

American Journal of Respiratory and Critical Care Medicine

Volumn 191, Issue 9, 2015, Pages 1024-1032

  Souweine, Bertrand ^a,b   Lautrette, Alexandre ^a,b   Gruson, Didier ^c   Canet, Emmanuel ^d   Klouche, Kada ^e   Argaud, Laurent ^f   Bohe, Julien ^g   Garrouste Orgeas, Maïté ^h   Mariat, Christophe ⁱ   Vincent, François ^j   Cayot, Sophie ^a   Cointault, Olivier ^k   Lepape, Alain ^g   Guelon, Dominique ^l   Darmon, Michael ⁱ   Vesin, Aurélien ^m   Caillot, Nicolas ^l   Schwebel, Carole ⁿ   Boyer, Alexandre ^c   Azoulay, Elie ^d   Bouadma, Lila ^o   Timsit, Jean François ^m,n   more..

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c HÔPITAL PELLEGRIN   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e LAPEYRONIE HOSPITAL   (France)

^f UNIVERSITÉ DE LYON   (France)

^g HOSPICES CIVILS DE LYON   (France)

^h SAINT JOSEPH HOSPITAL   (France)

ⁱ UNIVERSITÉ JEAN MONNET   (France)

^j Avicenne Teaching Hospital   (France)

^k CHU RANGUEIL   (France)

^l SERVICE DE RHUMATOLOGIE   (France)

^m INSTITUT ALBERT BONNIOT   (France)

ⁿ GRENOBLE UNIVERSITY HOSPITAL   (France)

^o BICHAT HOSPITAL   (France)

more..

Author keywords

Catheter related infection; Dialysis catheter; Ethanol; Prevention; Renal replacement therapy

Indexed keywords

ALCOHOL; PLACEBO; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; CATHETER INFECTION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIALYSIS CATHETER; DOUBLE BLIND PROCEDURE; FEMALE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PLASMAPHERESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; TREATMENT DURATION; ADVERSE EFFECTS; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERIZATION; CLINICAL TRIAL; CRITICAL ILLNESS; FRANCE; INDWELLING CATHETER; INFECTION CONTROL; INTENSIVE CARE; MIDDLE AGED; PROCEDURES;

AGED; ANTI-INFECTIVE AGENTS; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CRITICAL CARE; CRITICAL ILLNESS; DOUBLE-BLIND METHOD; ETHANOL; FEMALE; FRANCE; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 84929012269     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201408-1431OC     Document Type: Article

References (38)

1. Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 1999;20:396-401.
2. Renaud B, Brun-Buisson C; ICU-Bacteremia Study Group. Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 2001;163: 1584-1590.
3. Siempos II, Kopterides P, Tsangaris I, Dimopoulou I, Armaganidis AE. Impact of catheter-related bloodstream infections on the mortality of critically ill patients: a meta-analysis. Crit Care Med 2009;37: 2283-2289.
4. Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 2008;47:83-93.
5. Snaterse M, Rüger W, Scholte Op Reimer WJ, Lucas C. Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. J Hosp Infect 2010;75:1-11.
6. Li PK, Chow KM. Infectious complications in dialysis-epidemiology and outcomes. Nat Rev Nephrol 2012;8:77-88.
7. Landry DL, Braden GL, Gobeille SL, Haessler SD, Vaidya CK, Sweet SJ. Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol 2010;5:1799-1804.
8. Dixon JJ, Steele M, Makanjuola AD. Anti-microbial locks increase the prevalence of Staphylococcus aureus and antibiotic-resistant Enterobacter: observational retrospective cohort study. Nephrol Dial Transplant 2012;27:3575-3581.
9. Zhao Y, Li Z, Zhang L, Yang J, Yang Y, Tang Y, Fu P. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials. Am J Kidney Dis 2014; 63:479-490.
10. Balestrino D, Souweine B, Charbonnel N, Lautrette A, Aumeran C, Traoré O, Forestier C. Eradication of microorganisms embedded in biofilm by an ethanol-based catheter lock solution. Nephrol Dial Transplant 2009;24:3204-3209.
11. Metcalf SC, Chambers ST, Pithie AD. Use of ethanol locks to prevent recurrent central line sepsis. J Infect 2004;49:20-22.
12. Broom JK, Krishnasamy R, Hawley CM, Playford EG, Johnson DW. A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients-the HEALTHY-CATH trial. BMC Nephrol 2012;13:146.
13. Lesens O, Balestrino D, Charbonnel N, Aumeran C, TraoréO, Forestier C, Souweine B. Effectiveness of ethanol-based lock solutions on catheter biofilm microorganisms. Presented at the 53rd ICAAC. September 10-13, Denver, CO. p. 952.
14. Marik PE, Flemmer M, Harrison W. The risk of catheter-related bloodstream infection with femoral venous catheters as compared to subclavian and internal jugular venous catheters: a systematic review of the literature and meta-analysis. Crit Care Med 2012;40: 2479-2485.
15. Brun-Buisson C, Abrouk F, Legrand P, Huet Y, Larabi S, Rapin M. Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures. Arch Intern Med 1987;147:873-877.
16. Sherertz RJ, Raad II, Belani A, Koo LC, Rand KH, Pickett DL, Straub SA, Fauerbach LL. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 1990;28:76-82.
17. Schwab SJ, Weiss MA, Rushton F, Ross JP, Jackson J, Kapoian T, Yegge J, Rosenblatt M, Reese WJ, Soundararajan R, et al. Multicenter clinical trial results with the LifeSite hemodialysis access system. Kidney Int 2002;62:1026-1033.
18. Harb A, Estphan G, Nitenberg G, Chachaty E, Raynard B, Blot F. Indwelling time and risk of infection of dialysis catheters in critically ill cancer patients. Intensive Care Med 2005;31:812-817.
19. Souweine B, Liotier J, Heng AE, Isnard M, Ackoundou-N'Guessan C, Deteix P, TraoréO. Catheter colonization in acute renal failure patients: comparison of central venous and dialysis catheters. Am J Kidney Dis 2006;47:879-887.
20. Sanders J, Pithie A, Ganly P, Surgenor L, Wilson R, Merriman E, Loudon G, Judkins R, Chambers S. A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. J Antimicrob Chemother 2008;62:809-815.
21. Slobbe L, Doorduijn JK, Lugtenburg PJ, El Barzouhi A, Boersma E, van Leeuwen WB, Rijnders BJ. Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial. PLoS One 2010;5:e10840.
22. Pérez-Granda MJ, Barrio JM, Muñz P, Hortal J, Rincón C, Rabadán PM, Pernia MS, Bouza E. Ethanol lock therapy (E-Lock) in the prevention of catheter-related bloodstream infections (CR-BSI) after major heart surgery (MHS): a randomized clinical trial. PLoS One 2014;9:e91838.
23. Souweine B, Traore O, Aublet-Cuvelier B, Badrikian L, Bret L, Sirot J, Gazuy N, Laveran H, Deteix P. Dialysis and central venous catheter infections in critically ill patients: results of a prospective study. Crit Care Med 1999;27:2394-2398.
24. Parienti JJ, Thirion M, Mégarbane B, Souweine B, Ouchikhe A, Polito A, Forel JM, MarquéS, Misset B, Airapetian N, et al.; Members of the Cathedia Study Group. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 2008;299: 2413-2422.
25. Hermite L, Quenot JP, Nadji A, Barbar SD, Charles PE, Hamet M, Jacquiot N, Ghiringhelli F, Freysz M. Sodium citrate versus saline catheter locks for non-tunneled hemodialysis central venous catheters in critically ill adults: a randomized controlled trial. Intensive Care Med 2012;38:279-285.
26. Qu Y, Istivan TS, Daley AJ, Rouch DA, Deighton MA. Comparison of various antimicrobial agents as catheter lock solutions: preference for ethanol in eradication of coagulase-negative staphylococcal biofilms. J Med Microbiol 2009;58:442-450.
27. Vercaigne LM, Takla TA, Raghavan J. Long-term effect of an ethanol/sodium citrate locking solution on the mechanical properties of hemodialysis catheters. J Vasc Access 2010;11:12-16.
28. Guenu S, Heng AE, CharbonnéF, Galmier MJ, Charlés F, Deteix P, Souweine B, Lartigue C. Mass spectrometry and scanning electron microscopy study of silicone tunneled dialysis catheter integrity after an exposure of 15 days to 60% ethanol solution. Rapid Commun Mass Spectrom 2007;21:229-236.
29. Msakni N, Galmier MJ, Couret MJ, Szczepaniak C, Bouchon B, Souweine B, Lartigue C. Complementary mass spectrometric approaches and scanning electron microscopy to study the structural stability of polyurethane tunneled dialysis catheters after exposure to ethanol solutions. Rapid Commun Mass Spectrom 2013; 27:2343-2354.
30. Mermel LA, Alang N. Adverse effects associated with ethanol catheter lock solutions: a systematic review. J Antimicrob Chemother 2014; 69:2611-2619.
31. Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 2003;36: 1539-1544.
32. Maki DG, Ash SR, Winger RK, Lavin P; AZEPTIC Trial Investigators. A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial. Crit Care Med 2011;39:613-620.
33. Parienti JJ, Deryckére S, Mégarbane B, Valette X, Seguin A, Sauneuf B, Mira JP, Souweine B, Cattoir V, Daubin C, et al.; Cathedia Study Group. Quasi-experimental study of sodium citrate locks and the risk of acute hemodialysis catheter infection among critically ill patients. Antimicrob Agents Chemother 2014;58:5666-5672.
34. Mermel LA. What is the predominant source of intravascular catheter infections? Clin Infect Dis 2011;52:211-212.
35. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, et al.; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011;52:e162-e193.
36. Crnich CJ, Halfmann JA, Crone WC, Maki DG. The effects of prolonged ethanol exposure on the mechanical properties of polyurethane and silicone catheters used for intravascular access. Infect Control Hosp Epidemiol 2005;26:708-714.
37. Skofic N, Buturović-Ponikvar J, Kovac J, Premru V, Knap B, Marn Pernat A, Kersnic B, Gubensek J, Ponikvar R. Hemodialysis catheters with citrate locking in critically ill patients with acute kidney injury treated with intermittent online hemofiltration or hemodialysis. Ther Apher Dial 2009;13:327-333.
38. Chatzinikolaou I, Finkel K, Hanna H, Boktour M, Foringer J, Ho T, Raad I. Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study. Am J Med 2003;115:352-357.